Akihiko Ishiyama
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Genome sequencing provides high diagnostic yield and new etiological insights for intellectual disability and developmental delay.
Journal: NPJ genomic medicine
Published: March 11, 2025
Diagnostic Difficulty in a Girl With Anti-Signal Recognition Particle Myopathy With a Slow Progressive Course.
Journal: Journal of clinical neuromuscular disease
Published: November 26, 2024
Abnormal theta-band rhythm: EEG abnormality as potential biomarkers for disease severity in pediatric anti-NMDAR encephalitis.
Journal: Epilepsy & behavior reports
Published: June 20, 2024
Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy.
Journal: Cell reports. Medicine
Published: March 20, 2024
Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy in Children-A Literature Review.
Journal: Journal of clinical medicine
Published: December 09, 2023
Treatment of Spinal Muscular Atrophy
Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: May 17, 2023
Long-term Observation in Patients with Duchenne Muscular Dystrophy with Early Introduction of a Standing Program Using Knee-ankle-foot Orthoses.
Journal: Progress in rehabilitation medicine
Published: March 23, 2023
Myelin abnormalities in merosin-deficient congenital muscular dystrophy.
Journal: Muscle & nerve
Published: February 25, 2023
Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial.
Journal: Neuropsychopharmacology reports
Published: December 22, 2022
Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: A retrospective cohort study.
Journal: Brain & development
Published: September 02, 2022
Last Updated: 09/26/2026